Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 247

Similar articles for PubMed (Select 17316796)

1.

Animal models concerning the role of dopamine in attention-deficit hyperactivity disorder.

van der Kooij MA, Glennon JC.

Neurosci Biobehav Rev. 2007;31(4):597-618. Epub 2007 Jan 23. Review.

PMID:
17316796
2.

Brain iron: a promising noninvasive biomarker of attention-deficit/hyperactivity disorder that warrants further investigation.

Adisetiyo V, Helpern JA.

Biomark Med. 2015 May;9(5):403-6. doi: 10.2217/bmm.15.9. No abstract available.

3.

Psychiatric disorders: A zebrafish model of ADHD.

Whalley K.

Nat Rev Neurosci. 2015 Apr;16(4):188. doi: 10.1038/nrn3936. Epub 2015 Mar 4. No abstract available.

PMID:
25736022
4.

Circadian modulation of dopamine levels and dopaminergic neuron development contributes to attention deficiency and hyperactive behavior.

Huang J, Zhong Z, Wang M, Chen X, Tan Y, Zhang S, He W, He X, Huang G, Lu H, Wu P, Che Y, Yan YL, Postlethwait JH, Chen W, Wang H.

J Neurosci. 2015 Feb 11;35(6):2572-87. doi: 10.1523/JNEUROSCI.2551-14.2015.

PMID:
25673850
5.

[Analysis of dopamine transporter knockout mice as an animal model of AD/HD].

Kasahara Y, Kubo Y, Sora I.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2013 Nov;33(5-6):185-9. Review. Japanese.

PMID:
25069256
6.

Missense dopamine transporter mutations associate with adult parkinsonism and ADHD.

Hansen FH, Skjørringe T, Yasmeen S, Arends NV, Sahai MA, Erreger K, Andreassen TF, Holy M, Hamilton PJ, Neergheen V, Karlsborg M, Newman AH, Pope S, Heales SJ, Friberg L, Law I, Pinborg LH, Sitte HH, Loland C, Shi L, Weinstein H, Galli A, Hjermind LE, Møller LB, Gether U.

J Clin Invest. 2014 Jul;124(7):3107-20. doi: 10.1172/JCI73778. Epub 2014 Jun 9.

7.

Response to Selveraj et al.

Faraone SV, Spencer TJ, Madras BK, Zhang-James Y, Biederman J.

Mol Psychiatry. 2014 Sep;19(9):964-5. doi: 10.1038/mp.2014.26. Epub 2014 Apr 1. No abstract available.

PMID:
24686137
8.

ADHD, altered dopamine neurotransmission, and disrupted reinforcement processes: implications for smoking and nicotine dependence.

Kollins SH, Adcock RA.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jul 3;52:70-8. doi: 10.1016/j.pnpbp.2014.02.002. Epub 2014 Feb 18. Review.

9.

[Neurobiology of attention deficit hyperactivity disorder].

Wankerl B, Hauser J, Makulska-Gertruda E, Reißmann A, Sontag TA, Tucha O, Lange KW.

Fortschr Neurol Psychiatr. 2014 Jan;82(1):9-29. doi: 10.1055/s-0033-1355710. Epub 2014 Jan 20. Review. German.

PMID:
24446115
10.

Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: on the path to an animal model of attention-deficit hyperactivity disorder.

Mergy MA, Gowrishankar R, Davis GL, Jessen TN, Wright J, Stanwood GD, Hahn MK, Blakely RD.

Neurochem Int. 2014 Jul;73:56-70. doi: 10.1016/j.neuint.2013.11.009. Epub 2013 Dec 8. Review.

11.

Good riddance to dopamine: roles for the dopamine transporter in synaptic function and dopamine-associated brain disorders.

Gowrishankar R, Hahn MK, Blakely RD.

Neurochem Int. 2014 Jul;73:42-8. doi: 10.1016/j.neuint.2013.10.016. Epub 2013 Nov 11. Review.

PMID:
24231471
12.

Attention deficit hyperactivity disorder.

Matthews M, Nigg JT, Fair DA.

Curr Top Behav Neurosci. 2014;16:235-66. doi: 10.1007/7854_2013_249. Review.

13.
14.

Mechanisms of dopamine transporter regulation in normal and disease states.

Vaughan RA, Foster JD.

Trends Pharmacol Sci. 2013 Sep;34(9):489-96. doi: 10.1016/j.tips.2013.07.005. Epub 2013 Aug 20. Review.

15.

[Considerations regarding animal research of traditional Chinese medicine on attention deficit hyperactivity disorder].

Ni XQ, Zhang-James YL, Han XM.

Zhongguo Zhong Yao Za Zhi. 2013 Apr;38(7):1103-7. Chinese.

PMID:
23847968
16.

Transgenic mouse models for ADHD.

Leo D, Gainetdinov RR.

Cell Tissue Res. 2013 Oct;354(1):259-71. doi: 10.1007/s00441-013-1639-1. Epub 2013 May 17. Review.

17.

Gamma aminobutyric acid transporter subtype 1 gene knockout mice: a new model for attention deficit/hyperactivity disorder.

Yang P, Cai G, Cai Y, Fei J, Liu G.

Acta Biochim Biophys Sin (Shanghai). 2013 Jul;45(7):578-85. doi: 10.1093/abbs/gmt043. Epub 2013 May 8.

PMID:
23656791
18.

Low dopamine D5 receptor density in hippocampus in an animal model of attention-deficit/hyperactivity disorder (ADHD).

Medin T, Rinholm JE, Owe SG, Sagvolden T, Gjedde A, Storm-Mathisen J, Bergersen LH.

Neuroscience. 2013 Jul 9;242:11-20. doi: 10.1016/j.neuroscience.2013.03.036. Epub 2013 Mar 27.

PMID:
23541742
19.

Oroxylin A improves attention deficit hyperactivity disorder-like behaviors in the spontaneously hypertensive rat and inhibits reuptake of dopamine in vitro.

Yoon SY, dela Peña I, Kim SM, Woo TS, Shin CY, Son KH, Park H, Lee YS, Ryu JH, Jin M, Kim KM, Cheong JH.

Arch Pharm Res. 2013 Jan;36(1):134-40. doi: 10.1007/s12272-013-0009-6.

PMID:
23371806
20.

Amphetamine-induced locomotion in a hyperdopaminergic ADHD mouse model depends on genetic background.

O'Neill B, Gu HH.

Pharmacol Biochem Behav. 2013 Jan;103(3):455-9. doi: 10.1016/j.pbb.2012.09.020. Epub 2012 Sep 28.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk